Showing 721 - 740 results of 2,004 for search '"Breast cancer"', query time: 0.09s Refine Results
  1. 721
  2. 722
  3. 723

    CDK4 inactivation inhibits apoptosis via mitochondria-ER contact remodeling in triple-negative breast cancer by Dorian V. Ziegler, Kanishka Parashar, Lucia Leal-Esteban, Jaime López-Alcalá, Wilson Castro, Nadège Zanou, Laia Martinez-Carreres, Katharina Huber, Xavier Pascal Berney, María M. Malagón, Catherine Roger, Marie-Agnès Berger, Yves Gouriou, Giulia Paone, Hector Gallart-Ayala, George Sflomos, Carlos Ronchi, Julijana Ivanisevic, Cathrin Brisken, Jennifer Rieusset, Melita Irving, Lluis Fajas

    Published 2025-01-01
    “…While CDK4 is known for its role in cell proliferation, its metabolic function in cancer, particularly in triple-negative breast cancer (TNBC), remains unclear. Our study, using genetic and pharmacological approaches, reveals that CDK4 inactivation only modestly impacts TNBC cell proliferation and tumor formation. …”
    Get full text
    Article
  4. 724
  5. 725
  6. 726

    Let-7b-5p sensitizes breast cancer cells to doxorubicin through Aurora Kinase B. by Murat Kaya, Asmaa Abuaisha, Ilknur Suer, Selman Emiroglu, Semen Önder, Evren Onay Ucar, Mustafa Nuri Yenerel, Sukru Palanduz, Kivanc Cefle, Sukru Ozturk, Zeyneb Kurt

    Published 2025-01-01
    “…It has been proven that deregulated miRNAs may play an essential role in the progression of breast cancer. It has been shown in many cancers, including breast cancer, that aberrant expression of miRNAs may be associated with drug resistance. …”
    Get full text
    Article
  7. 727
  8. 728
  9. 729
  10. 730
  11. 731

    Association between Neurofibromatosis Type 1 and Breast Cancer: A Report of Two Cases with a Review of the Literature by Yoon Nae Seo, Young Mi Park

    Published 2015-01-01
    “…Neurofibromatosis type 1 (NF1) is one of the most common genetic diseases in humans and is associated with various benign and malignant tumors, including breast cancer. However, an increased risk of breast cancer in NF1 patients has not been widely recognized or accepted. …”
    Get full text
    Article
  12. 732
  13. 733
  14. 734
  15. 735

    Injectable supramolecular hydrogel co-loading abemaciclib/NLG919 for neoadjuvant immunotherapy of triple-negative breast cancer by Binyu Zhu, Ying Cai, Lingli Zhou, Lei Zhao, Jiameng Chen, Xiaoting Shan, Xujie Sun, Qian You, Xiang Gong, Wen Zhang, Helen He Zhu, Pengcheng Zhang, Yaping Li

    Published 2025-01-01
    “…Abstract The efficacy of cancer immunotherapy relies on a sufficient amount of functional immune cells. Triple-negative breast cancer lacks enough immune cell infiltration, and adjuvant therapy is necessary to prime anti-tumor immunity. …”
    Get full text
    Article
  16. 736
  17. 737
  18. 738

    Clinicopathological Features and Prognoses of Patients With Splenic Metastases From Breast Cancer: A Single-Centre, Retrospective Study by Xiaofeng Xie MD, Mingrui Ma MD, Xue Bai BS, Jing Hu MD, Haijie Zheng MD, Xiongqi Guo BS, Jiayi Huang MD, Xuelian Chen PhD, Liping Chen BS, Xiaofeng Lan BS, Lin Song BS, Caiwen Du PhD

    Published 2025-12-01
    “…Purpose Splenic metastases (SM) from breast cancer (SMBC) are exceedingly rare. To date, the relevant literature is primarily based on pan-tumour species, with only a few studies exploring SM specifically in relation to breast cancer. …”
    Get full text
    Article
  19. 739
  20. 740